These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 25197370

  • 1. Clinicopathological characteristics of four cases of EBV positive T-cell lymphoproliferative disorders of childhood in China.
    Huang W, Lv N, Ying J, Qiu T, Feng X.
    Int J Clin Exp Pathol; 2014; 7(8):4991-9. PubMed ID: 25197370
    [Abstract] [Full Text] [Related]

  • 2. [Clinicopathologic features of systemic EBV-positive T-cell lymphoproliferative disease of childhood].
    Jin Y, Zhou XG, He LJ, Xie JL, Zheng YY, Zhang YN, Zhang SH.
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):600-8. PubMed ID: 20079188
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
    Zheng XD, Zhou XG, Jin Y, Xie JL, Wei XJ, Chen SY, Mei X, Gong LP, Lü BB.
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
    [Abstract] [Full Text] [Related]

  • 7. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC, Chang ST, Hsieh YC, Huang WT, Hsu JD, Tseng CE, Wang MC, Hwang WS, Wang J, Chuang SS.
    Int J Clin Exp Pathol; 2014 Apr; 7(5):2430-7. PubMed ID: 24966953
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
    Kawabe S, Ito Y, Gotoh K, Kojima S, Matsumoto K, Kinoshita T, Iwata S, Nishiyama Y, Kimura H.
    Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
    Smith MC, Cohen DN, Greig B, Yenamandra A, Vnencak-Jones C, Thompson MA, Kim AS.
    Int J Clin Exp Pathol; 2014 Aug; 7(9):5738-49. PubMed ID: 25337215
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
    Wang X, Liang Y, Yang Y, Li W, Wang G, Wang S, Li Y, Zhang M.
    J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS, Oon ML, Wang S, Tan SY, Ng SB.
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.